| Date | Title | Description |
| 20.04.2023 | SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023 | BOULDER, Colo., April 20, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market close on Thursday, May 11, 2023. Management... |
| 13.06.2022 | SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics | BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-gene... |
| 12.01.2022 | OncoHost Announces Interim Results from PROPHETIC Trial, Multicenter Assessment of NSCLC Patient Response to Immunotherapy | BINYAMINA, Israel, Jan. 12, 2022 /PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These... |
| 12.01.2022 | OncoHost Announces Interim Results from PROPHETIC Trial, Multicenter Assessment of NSCLC Patient Response to Immunotherapy | BINYAMINA, Israel, Jan. 12, 2022 /PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These... |
| 01.11.2021 | SomaLogic announces strategic collaboration with University Hospitals Cleveland Medical Center to treat diabetic patients at high risk of cardiovascular disease | BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading academic medical centers, University Hospi... |
| 06.09.2021 | SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker SLGC | SomaLogic, Inc., a leader in AI-data driven proteomics technology, announced that it has completed its business combination with CM Life Sciences II, Inc., a special purpose acquisition company sponsored by affiliates of leading healthcare ... |
| 31.08.2021 | SomaLogic expands leadership team with new positions to drive commercial success | NEW YORK and BOULDER, Colo., Aug. 31, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today announced the recent appointments of Todd Johnson as Executive Vice Pr... |
| 03.08.2021 | SomaLogic Announces Appointment Of Shaun Blakeman As Chief Financial Officer | CM Life Sciences II and SomaLogic, a leader in AI-data driven proteomics technology, announced the appointment of Shaun Blakeman as the company’s Chief Financial Officer.
SysAdmin Appreciation Day: Top Industry Leaders Share their Insights ... |
| 29.03.2021 | SomaLogic To Go Public Via SPAC | SomaLogic, a Boulder, CO-based global leader in proteomics technology, and CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, entered into a d... |
| 04.01.2021 | SomaLogic Adds $81 Million To Current Funding Round, Bringing Total To $214 Million | SomaLogic — a leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics — announced that it added $81 million to its current funding round
SomaLogic — a leader in proteomic discovery and appli... |
| 24.12.2020 | SomaLogic Raises Additional $81M to Series A Financing Totaling $214M | SomaLogic, Inc., a Boulder, CO-based global developer of proteomic discovery and applications for biomedical discovery and clinical diagnostics, added $81M to Series A raise which now totals $214M.
In this second close, additional financial... |
| 23.12.2020 | SomaLogic Adds $81 Million to Series A Financing Totaling $214 Million | SomaLogic, global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced that it added $81 Million to its current funding round with investments from a number of additional inves... |
| 23.12.2020 | Oscar Raises $140M, Babylon Health, Modern Health, Diameter Health, Curai Health, Others Recent Digital Health Funding | Oscar Raises $140M, Confidentiality Files for IPO
Oscar, the first health insurance company built on a full stack technology platform raises $140M in funding led by Tiger Global Management, LLC, with participation from Dragoneer, Baillie Gi... |
| 22.12.2020 | SomaLogic Adds $81M to Series A Financing Totaling $214M | BOULDER, Colo., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that it added $81M to its current funding r... |
| 25.11.2020 | Boulder’s SomaLogic raises $121M in Series A round, setting record for 2020 fundraising in region | Blood protein testmaker SomaLogic Inc. has secured $121 million in its Series A financing round, making it the largest venture-capital round in the region so far this year.
In a statement, the Boulder company said the round was led by New Y... |
| 25.11.2020 | SomaLogic Closes $121M Series A Financing Led by Casdin Capital | BOULDER, Colo., Nov. 25, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an... |
| 04.09.2019 | SomaLogic launches its firsts SomaSignal tests in Colorado | Boulder’s SomaLogic on Wednesday launched its first SomaSignal tests that can provide precise medical information about a person’s cardiometabolic health.
The laboratory-developed tests measure thousands of proteins in a blood sample.The me... |
| 05.01.2018 | Term Sheet — Friday, January 5 | THE BILLIONAIRE CLUB
Happy Friday, Term Sheet readers!
Paid Content Securing the enterprise without boundaries From ExtraHop
Things changed this week. Kalanick plans to sell 29% of his stake in Uber. This means the ex-CEO will sell equity w... |
| 04.01.2018 | Madryn Joins $200M Funding for SomaLogic | SomaLogic announced today that it has capped its $200 million funding round, anchored by iCarbonX with substantial investments from Nan Fung Life Sciences and Madryn Asset Management. The successful round will accelerate SomaLogic’s goal of... |
| 04.01.2018 | SomaLogic Closes $200M Financing Round | SomaLogic, a Boulder, CO-based provider of a platform that delivers actionable health-management insights for individuals to optimize their personal health and wellness, closed a $200m funding round.
The round was anchored by iCarbonX with ... |
| 06.01.2017 | $100M PatientsLikeMe-iCarbonX deal highlights huge day in digital health investment | PatientsLikeMe is getting a huge cash infusion while also expanding its genomics capabilities.
The patient social network on Thursday announced at least $100 million in new investment, courtesy of a partnership with Chinese startup iCarbonX... |
| 24.06.2016 | Proteomics shows promise for assessing risk of heart attacks and strokes | Proteomics may be more accurate than assessing those traditional risk factors because “proteins are one step closer to the disease itself,” explained Dr. Peter Ganz, the study’s principal investigator and a professor of medicine at the Univ... |
| 01.03.2016 | SomaLogic Raises $60.5M |
BOULDER, CO, SomaLogic and Visium Healthcare Partners, LP today announced that SomaLogic will receive up to $60.5 million through a combination of debt and equity financing from Visium.
>> Click here for more funding data on SomaLo... |
| 01.03.2016 | SomaLogic to Raise up to $60.5M in Debt and Equity Financing | SomaLogic, Inc., a Boulder, CO-based medical diagnostic technology company, is to raise up to $60.5m in debt and equity financing.
Visium Healthcare Partners will provide the funds.
The company intends to use the funds for continued growth,... |
| 10.11.2014 | Right after Novartis takes stake in proteomics company, it raises $16.5M | SomaLogic has outlined its proteomics applications in a number of spaces:
Though the privately held SomaLogic has been around more than a decade, it’s raised $46.5 million since 2010.
Promoted
This Patient Experience Checklist Is Your Key T... |
| 30.08.2013 | SomaLogic Raises $10M in Funding | SomaLogic, a Bolder, CO-based protein biomarker discovery and clinical diagnostics company, raised $10m in funding.
A filing with the S.E.C. lists a single (undisclosed) investor.
Larry Gold, Ph.D., Chairman and CEO, SomaLogic develops nove... |
| 23.08.2013 | Mile High Roundup: Spaceships, SomaLogic Stays Silent, and SanDisk | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Welcome to the Mile High Roundup, a look at some of the interesting things that have happened over the past two weeks in the tech scene in Boulder, Denver, and around Colorado... |
| - | Proteomics shows promise for assessing risk of heart attacks and strokes | The promise of proteomics—measuring protein levels—as a tool for assessing risk of heart attacks and strokes was highlighted in a new study in the Journal of the American Medical Association.
In this study, published this week, researchers ... |
| - | Right after Novartis takes stake in proteomics company, it raises $16.5M | Just a few weeks after Novartis announced it’s taken an ownership stake in Colorado’s SomaLogic, the proteomics company has raised $16.5 million, according to a regulatory filing.
Although SomaLogic’s keeping quiet on who’s invested and wha... |
| - | $100M PatientsLikeMe-iCarbonX deal highlights huge day in digital health investment | PatientsLikeMe is getting a huge cash infusion while also expanding its genomics capabilities.
The patient social network on Thursday announced at least $100 million in new investment, courtesy of a partnership with Chinese startup iCarbonX... |
| - | Real-world data and Covid-19: Extending the measurable phenotype | Real-world evidence is only as good as the real-world data from which it is derived. While real-world data has traditionally included electronic health records, registries, claims and billing info, and self-reported patient data, the FDA an... |
